Why the study?
The study aimed to analyze the associations between no-reflow phenomenon development and whole-blood viscosity in patients with ST-elevated myocardial infarction.
Does increased whole-blood viscosity predict the development of no-reflow phenomenon in patients with ST-elevated myocardial infarction undergoing primary percutaneous coronary interventions?
Does increased whole-blood viscosity predict the development of no-reflow phenomenon in patients with ST-elevated myocardial infarction undergoing primary percutaneous coronary interventions?
Increased whole-blood viscosity is an independent predictor of the no-reflow phenomenon in patients with STEMI undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
Whole-blood viscosity may aid no-reflow risk stratification in STEMI PCI; hypothesis-generating and requires prospective validation before clinical use.
Background: This study aimed to analyze the associations between no-reflow (NR) phenomenon development and whole-blood viscosity in patients with ST-elevated myocardial infarction. Methods: A total of 217 patients with ST-elevated myocardial infarction were included. whole-blood viscosity values were assessed using hematocrit and total protein values, and low shear rate (LSR) and high shear rate (HSR) were calculated. Results: The average LSR and HSR values of the study group were significantly higher than the control group (p < 0.001). Multivariate logistic regression analysis showed that both HSR (odds ratio: 4.957; p < 0.001) and LSR (odds ratio: 1.114; p < 0.001) were independent predictors for NR development. Conclusion: This study found that increased blood viscosity was an independent predictor for NR development.
No takes yet. Share an insight, caveat, or question.
Yıldırım et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: